Acquisitions (Tables)

6 Months Ended

Jun. 30, 2019

Business Combinations [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The purchase price was allocated as follows (in thousands):

Inventories	$	971
Intangibles
Developed technology	4,840
Customer list	120
Trademarks	400
Goodwill	938
Total net assets acquired	$	7,269

The following table summarizes the purchase price allocated to the assets acquired from BD (in thousands):

Inventories	$	5,804
Property and equipment	748
Intangibles
Developed technology	74,000
Customer list	4,200
Trademarks	4,900
In-process technology	2,500
Goodwill	9,728
Total net assets acquired	$	101,880

The following table summarizes the preliminary purchase price allocated to the net assets acquired from Cianna Medical (in thousands):

Assets Acquired
Trade receivables	$	6,151
Inventories	5,803
Prepaid expenses and other current assets	315
Property and equipment	1,047
Other long-term assets	14
Intangibles
Developed technology	134,510
Customer lists	3,330
Trademarks	7,080
Goodwill	65,802
Total assets acquired	224,052
Liabilities Assumed
Trade payables	(1,497		)
Accrued expenses	(2,384		)
Other long-term liabilities	(1,527		)
Deferred income tax liabilities	(30,363		)
Total liabilities assumed	(35,771		)
Total net assets acquired	$	188,281

The purchase price was preliminarily allocated as follows (in thousands):

Assets Acquired
Trade receivables	$	94
Inventories	349
Property and equipment	409
Other long-term assets	30
Intangibles
Developed technology	31,680
Customer lists	83
Trademarks	250
Goodwill	16,950
Total assets acquired	49,845
Liabilities Assumed
Trade payables	(58		)
Accrued expenses	(261		)
Other long-term obligations	(1,522		)
Deferred income tax liabilities	(4,590		)
Total liabilities assumed	(6,431		)
Total net assets acquired	$	43,414

The purchase price was preliminarily allocated as follows (in thousands):

Inventories	$	1,353
Intangibles
Developed technology	32,750
Customer list	840
Trademarks	1,410
Goodwill	21,847
Total net assets acquired	$	58,200

Business Acquisition, Pro Forma Information

The following table summarizes our consolidated results of operations for the three and six-month periods ended June 30, 2018, as well as unaudited pro forma consolidated results of operations as though the acquisition of Cianna Medical and Vascular Insights had occurred on January 1, 2017 (in thousands, except per common share amounts):

	Three Months Ended				Six Months Ended
	June 30, 2018				June 30, 2018
	As Reported		Pro Forma		As Reported		Pro Forma
Net sales	$	224,810	$	238,272	$	427,844	$	452,451
Net income	10,941		6,842		16,210		5,016
Earnings per common share:
Basic	$	0.22	$	0.14	$	0.32	$	0.10
Diluted	$	0.21	$	0.13	$	0.31	$	0.10

* The pro forma results for the three and six-month periods ended June 30, 2019 are not included in the table above because the

operating results for the Cianna Medical and Vascular Insights acquisitions were included in our consolidated statements of income for these periods.